Skip to main content
Top

24-02-2024 | Overactive Bladder | REVIEW

Predictive Value of Urodynamic Studies for Overactive Bladder

Authors: Greeshma Venigalla, Megan Sherwood, Alan Wein, Katherine Amin, Raveen Syan

Published in: Current Bladder Dysfunction Reports

Login to get access

Abstract

Purpose of Review

The use of urodynamic studies (UDS) in overactive bladder (OAB) diagnosis is contested due to concerns of invasiveness, cost-effectiveness, and relative lack of impact on treatment strategy. We aimed to provide a comprehensive review of the role of UDS in the diagnosis of refractory OAB, while also providing a synthesis of recent studies on this topic.

Recent Findings

Recent studies that endorse the use of UDS show that incorporation of UDS findings may increase patient compliance and satisfaction with OAB treatment. Studies suggest that this greater patient satisfaction may be attributed to the ability of UDS to better identify the unique pathophysiology of OAB for each patient. One study found that UDS is also useful in diagnosing comorbid conditions, thereby affording clinicians the ability to individually tailor treatment. However, other studies showed that UDS did not significantly change the diagnosis and management in cases of uncomplicated OAB.

Summary

The use of UDS in the diagnostic algorithm of OAB may depend on the degree of certainty needed by individual providers to make a diagnosis and the extent to which findings would change the course of treatment. Individual patient history, clinical manifestations, and reported symptoms will influence further the appropriateness of UDS in given scenarios. Future studies are needed to better delineate the role of UDS in the assessment and management of refractory OAB.
Literature
1.
go back to reference White N, Iglesia CB. Overactive bladder. Obstet Gynecol Clin. 2016;43(1):59–68.CrossRef White N, Iglesia CB. Overactive bladder. Obstet Gynecol Clin. 2016;43(1):59–68.CrossRef
3.
go back to reference Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog A, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.CrossRefPubMed Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog A, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.CrossRefPubMed
8.
go back to reference Cho KJ, Kim HS, Koh JS, Kim JC. Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction. Int Braz J Urol Off J Braz Soc Urol. 2015;41(4):722–8.CrossRef Cho KJ, Kim HS, Koh JS, Kim JC. Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction. Int Braz J Urol Off J Braz Soc Urol. 2015;41(4):722–8.CrossRef
10.
go back to reference Hsu CC, Liang CC, Chang SD, Chien CW, Hsieh WC. Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder. Taiwan J Obstet Gynecol. 2020;59(1):39–42.CrossRefPubMed Hsu CC, Liang CC, Chang SD, Chien CW, Hsieh WC. Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder. Taiwan J Obstet Gynecol. 2020;59(1):39–42.CrossRefPubMed
11.
go back to reference Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, et al. Defining overactive bladder as hypersensitivity. Neurourol Urodyn. 2007;26(S6):904–7.CrossRefPubMed Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, et al. Defining overactive bladder as hypersensitivity. Neurourol Urodyn. 2007;26(S6):904–7.CrossRefPubMed
12.
go back to reference Chen LC, Kuo HC. Pathophysiology of refractory overactive bladder. LUTS Low Urin Tract Symptoms. 2019;11(4):177–81.CrossRefPubMed Chen LC, Kuo HC. Pathophysiology of refractory overactive bladder. LUTS Low Urin Tract Symptoms. 2019;11(4):177–81.CrossRefPubMed
13.
go back to reference Wein AJ. Diagnosis and treatment of the overactive bladder. Urology. 2003;62(5, Supplement 2):20–7. Wein AJ. Diagnosis and treatment of the overactive bladder. Urology. 2003;62(5, Supplement 2):20–7.
14.
go back to reference Smith A, Bevan D, Douglas HR, James D. Management of urinary incontinence in women: summary of updated NICE guidance. BMJ. 2013;347: f5170.CrossRefPubMed Smith A, Bevan D, Douglas HR, James D. Management of urinary incontinence in women: summary of updated NICE guidance. BMJ. 2013;347: f5170.CrossRefPubMed
15.
go back to reference Phé V, de Wachter S, Rouprêt M, Chartier-Kastler E. How to define a refractory idiopathic overactive bladder? Neurourol Urodyn. 2015;34(1):2–11.CrossRefPubMed Phé V, de Wachter S, Rouprêt M, Chartier-Kastler E. How to define a refractory idiopathic overactive bladder? Neurourol Urodyn. 2015;34(1):2–11.CrossRefPubMed
16.
go back to reference Fontaine C, Papworth E, Pascoe J, Hashim H. Update on the management of overactive bladder. Ther Adv Urol. 2021;13:175628722110390.CrossRef Fontaine C, Papworth E, Pascoe J, Hashim H. Update on the management of overactive bladder. Ther Adv Urol. 2021;13:175628722110390.CrossRef
17.
go back to reference Abdel-fattah M, Chapple C, Guerrero K, Dixon S, Cotterill N, Ward K, et al. Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms. Trials. 2021;22(1):745.CrossRefPubMedPubMedCentral Abdel-fattah M, Chapple C, Guerrero K, Dixon S, Cotterill N, Ward K, et al. Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms. Trials. 2021;22(1):745.CrossRefPubMedPubMedCentral
19.
go back to reference Winters JC, Dmochowski RR, Goldman HB, Herndon CDA, Kobashi KC, Kraus SR, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012;188(6S):2464–72.CrossRefPubMed Winters JC, Dmochowski RR, Goldman HB, Herndon CDA, Kobashi KC, Kraus SR, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012;188(6S):2464–72.CrossRefPubMed
20.
go back to reference Kim SH, Kim TB, Kim SW, Oh SJ. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder. J Urol. 2009;181(6):2550–4.CrossRefPubMed Kim SH, Kim TB, Kim SW, Oh SJ. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder. J Urol. 2009;181(6):2550–4.CrossRefPubMed
21.
go back to reference Robinson D, Staskin D, Laterza RM, Koelbl H. Defining female voiding dysfunction: ICI-RS 2011. Neurourol Urodyn. 2012;31(3):313–6.CrossRefPubMed Robinson D, Staskin D, Laterza RM, Koelbl H. Defining female voiding dysfunction: ICI-RS 2011. Neurourol Urodyn. 2012;31(3):313–6.CrossRefPubMed
22.
go back to reference Yeniel AÖ, Ergenoğlu MA, Meseri R, Aşkar N, İtil İM. How frequent are overactive bladder symptoms in women with urodynamic verification of an overactive bladder? J Turk Ger Gynecol Assoc. 2012;13(2):98–101.CrossRefPubMedPubMedCentral Yeniel AÖ, Ergenoğlu MA, Meseri R, Aşkar N, İtil İM. How frequent are overactive bladder symptoms in women with urodynamic verification of an overactive bladder? J Turk Ger Gynecol Assoc. 2012;13(2):98–101.CrossRefPubMedPubMedCentral
23.
go back to reference Malone-Lee J, Henshaw DJE, Cummings K. Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response. BJU Int. 2003;92:415–7.CrossRefPubMed Malone-Lee J, Henshaw DJE, Cummings K. Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response. BJU Int. 2003;92:415–7.CrossRefPubMed
24.•
go back to reference Huang TX, Lo TS, Tseng HJ, Lin YH, Liang CC, Hsieh WC. Correlation between overactive bladder and detrusor overactivity: a retrospective study. Int Urogynecology J. 2023;34(4):867–75. This retrospective review assessed the prevalence of OAB and DO for female patients referred for UDS to conclude that UDS may offer objective findings that combined with subjective findings may improve diagnosis and outcomes for these patients. Huang TX, Lo TS, Tseng HJ, Lin YH, Liang CC, Hsieh WC. Correlation between overactive bladder and detrusor overactivity: a retrospective study. Int Urogynecology J. 2023;34(4):867–75. This retrospective review assessed the prevalence of OAB and DO for female patients referred for UDS to conclude that UDS may offer objective findings that combined with subjective findings may improve diagnosis and outcomes for these patients.
25.•
go back to reference Serati M, Iacovelli V, Cantaluppi S, et al. Impact of urodynamic evaluation on the treatment of women with idiopathic overactive bladder: a systematic review. Minerva Urol Nefrol. 2020;72(4):420-426. https://doi.org/10.23736/S0393-2249.20.03685-1. This systemic review assesses the role of UDS in guiding idiopathic OAB management and outcomes in women. Serati M, Iacovelli V, Cantaluppi S, et al. Impact of urodynamic evaluation on the treatment of women with idiopathic overactive bladder: a systematic review. Minerva Urol Nefrol. 2020;72(4):420-426. https://​doi.​org/​10.​23736/​S0393-2249.​20.​03685-1This systemic review assesses the role of UDS in guiding idiopathic OAB management and outcomes in women.
26.•
go back to reference Verghese TS, Middleton LJ, Daniels JP, Deeks JJ, Latthe PM. The impact of urodynamics on treatment and outcomes in women with an overactive bladder: a longitudinal prospective follow-up study. Int Urogynecol J. 2018;29(4):513–9. This longitudinal prospective follow up study evaluated whether UDS changed management and patient-reported outcomes for women with OAB. Verghese TS, Middleton LJ, Daniels JP, Deeks JJ, Latthe PM. The impact of urodynamics on treatment and outcomes in women with an overactive bladder: a longitudinal prospective follow-up study. Int Urogynecol J. 2018;29(4):513–9. This longitudinal prospective follow up study evaluated whether UDS changed management and patient-reported outcomes for women with OAB.
27.•
go back to reference Serati M, Cantaluppi S, Coluccia AC, et al. Is urodynamic evaluation able to change and improve the management of women with idiopathic overactive bladder?. Minerva Urol Nephrol. 2021;73(6):823-830. https://doi.org/10.23736/S2724-6051.20.03801-1. This trial compared management and outcomes for women that declined or received UDS for idiopathic OAB. Serati M, Cantaluppi S, Coluccia AC, et al. Is urodynamic evaluation able to change and improve the management of women with idiopathic overactive bladder?. Minerva Urol Nephrol. 2021;73(6):823-830. https://​doi.​org/​10.​23736/​S2724-6051.​20.​03801-1This trial compared management and outcomes for women that declined or received UDS for idiopathic OAB.
28.•
go back to reference English K, Maiman R, Laudano M, Abraham N. Urodynamics less likely to change diagnosis and management in uncomplicated overactive bladder. Can J Urol. 2020;27(3):10244–10249. This retrospective review evaluated the impact of UDS on diagnosis and management for women with uncomplicated urinary incontinence. English K, Maiman R, Laudano M, Abraham N. Urodynamics less likely to change diagnosis and management in uncomplicated overactive bladder. Can J Urol. 2020;27(3):10244–10249. This retrospective review evaluated the impact of UDS on diagnosis and management for women with uncomplicated urinary incontinence.
29.•
go back to reference Nager CW, Brubaker L, Litman HJ, Zyczynski HM, Varner RE, Amundsen C, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med. 2012;366:1987–97. This VALUE trial compared UDS testing to preoperative office testing on diagnosis, treatment selection and outcomes for women with SUI. Nager CW, Brubaker L, Litman HJ, Zyczynski HM, Varner RE, Amundsen C, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med. 2012;366:1987–97. This VALUE trial compared UDS testing to preoperative office testing on diagnosis, treatment selection and outcomes for women with SUI.
30.
go back to reference van Leijsen SAL, Kluivers KB, Mol BWJ, Broekhuis SR, Milani AL, Bongers MY, et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn. 2012;31(7):1118–23.CrossRefPubMed van Leijsen SAL, Kluivers KB, Mol BWJ, Broekhuis SR, Milani AL, Bongers MY, et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn. 2012;31(7):1118–23.CrossRefPubMed
31.
go back to reference Finazzi-Agro E, Gammie A, Kessler TM, van Koeveringe G, Serati M, Solomon E, et al. Urodynamics useless in female stress urinary incontinence? Time for some sense—a European expert consensus. Eur Urol Focus. 2020;6(1):137–45.CrossRefPubMed Finazzi-Agro E, Gammie A, Kessler TM, van Koeveringe G, Serati M, Solomon E, et al. Urodynamics useless in female stress urinary incontinence? Time for some sense—a European expert consensus. Eur Urol Focus. 2020;6(1):137–45.CrossRefPubMed
33.
go back to reference Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202:558–63.CrossRefPubMed Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202:558–63.CrossRefPubMed
Metadata
Title
Predictive Value of Urodynamic Studies for Overactive Bladder
Authors
Greeshma Venigalla
Megan Sherwood
Alan Wein
Katherine Amin
Raveen Syan
Publication date
24-02-2024
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-024-00743-9